Advertisement
Advertisement
CRDL
Cardiol Therapeutics Inc. Class A Common Shares
1.06
USDSponsored
+0.03
+3.40%
Jun 25, 12:25 UTC -4
Open
CRDL Earnings Reports
Positive Surprise Ratio
CRDL beat 17 of 23 last estimates.
74%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.10
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Cardiol Therapeutics Inc. Class A Common Shares earnings per share and revenue
On May 26, 2026, CRDL reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.10 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.52% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Cardiol Therapeutics Inc. Class A Common Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Cardiol Therapeutics Inc. Class A Common Shares reported EPS of -$0.10, beating estimates by 1.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Cardiol Therapeutics Inc. Class A Common Shares's Q1 2026 earnings?
The stock price moved down -1.52%, changed from $1.32 before the earnings release to $1.30 the day after.
When is Cardiol Therapeutics Inc. Class A Common Shares expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Cardiol Therapeutics Inc. Class A Common Shares's next earnings report?
Based on --
analysts, Cardiol Therapeutics Inc. Class A Common Shares is expected to report EPS of -$0.10 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement